InvestSMART

MedAdvisor Limited (ASX: MDR) - Announcements

Current share price for MDR : $0.022 0.002 (10%)+

ASX company news and announcements for MedAdvisor Limited (MDR) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All MedAdvisor Limited (MDR) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than MedAdvisor Limited (MDR), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for MedAdvisor Limited (MDR)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
- MDR Cleansing Notice - Employee Shares and Options 17 Nov 2020 9:41AM $0.425 $0.022 fallen by 94.82%
- MDR Appendix 3G - Issue of Employee Incentive Options 17 Nov 2020 9:41AM $0.425 $0.022 fallen by 94.82%
- MDR Appendix 2A - Exercise of Employee Options 17 Nov 2020 9:39AM $0.425 $0.022 fallen by 94.82%
- MDR Appendix 2A - Placement & ANREO 17 Nov 2020 9:37AM $0.425 $0.022 fallen by 94.82%
- Retail Entitlement Offer - Letter to Ineligible Shareholders 17 Nov 2020 9:21AM $0.425 $0.022 fallen by 94.82%
- MedAdvisor's Retail Entitlement Offer Commences 17 Nov 2020 9:19AM $0.425 $0.022 fallen by 94.82%
- MedAdvisor extends Health Programs in the US 13 Nov 2020 10:21AM $0.400 $0.022 fallen by 94.50%
- Reinstatement to Official Quotation 12 Nov 2020 10:31AM $0.400 $0.022 fallen by 94.50%
- MDR successfully completes Placement & Institutional Offer 12 Nov 2020 10:31AM $0.400 $0.022 fallen by 94.50%
- MDR Updated Appendix 3B due to change in ANREO timetable 10 Nov 2020 1:53PM $0.400 $0.022 fallen by 94.50%
- MedAdvisor requests extended voluntary trading suspension 10 Nov 2020 11:17AM $0.400 $0.022 fallen by 94.50%
- MedAdvisor - Request for further Voluntary Suspension 10 Nov 2020 9:28AM $0.400 $0.022 fallen by 94.50%
- MDR Cleansing Notice for Entitlement Offer of $0.38 6 Nov 2020 12:01PM $0.400 $0.022 fallen by 94.50%
- MDR Appendix 3B - Updated for 38c raise 6 Nov 2020 12:01PM $0.400 $0.022 fallen by 94.50%
- MDR Investor Presentation Update - Adheris Acquisition 6 Nov 2020 12:01PM $0.400 $0.022 fallen by 94.50%
- MDR adjusts price for capital raise, targeting $45m raise 6 Nov 2020 12:00PM $0.400 $0.022 fallen by 94.50%
- Suspension from Official Quotation 6 Nov 2020 9:53AM $0.400 $0.022 fallen by 94.50%
- MDR Cleansing notice for ANREO 2 Nov 2020 11:30AM $0.400 $0.022 fallen by 94.50%
- MedAdvisor Appendix 3B 2 Nov 2020 11:29AM $0.400 $0.022 fallen by 94.50%
- MDR Investor presentation - Adheris acquisition & Cap raise 2 Nov 2020 11:29AM $0.400 $0.022 fallen by 94.50%
- Trading Halt Request (Updated) 2 Nov 2020 11:28AM $0.400 $0.022 fallen by 94.50%
- MDR to acquire US-based Adheris Health & targets $45m raise 2 Nov 2020 11:28AM $0.400 $0.022 fallen by 94.50%
- Trading Halt 2 Nov 2020 10:26AM $0.400 $0.022 fallen by 94.50%
- Pause in Trading 2 Nov 2020 9:52AM $0.400 $0.022 fallen by 94.50%
- Change in substantial holding 29 Oct 2020 4:28PM $0.390 $0.022 fallen by 94.36%

451 - 475 of 761 results

Page 19 of 31

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.